BioPharma Credit PLC Cash Flow Quality Index
BioPharma Credit PLC cash flow quality index. BioPharma Credit PLC (BPCR) has a Cash Flow Quality Index of 0.46x as of June 2025. Operating cash flow of $33.76 Million is below net income of $72.78 Million, suggesting accrual-heavy earnings not yet converted to cash. See BPCR free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of BioPharma Credit PLC (2017–2024)
Cash flow quality index of BioPharma Credit PLC from 2017 to 2024. Historical Cash Flow Quality Index for BioPharma Credit PLC across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore BioPharma Credit PLC (BPCR) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
BioPharma Credit PLC Cash Flow Quality Index by Year (2017–2024)
BioPharma Credit PLC cash flow quality index by year from 2017 to 2024. Year-by-year earnings quality comparison for BioPharma Credit PLC. For the full cash flow conversion analysis, see BPCR operating cash flow.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.92x | $111.91 Million | $122.18 Million | ▼ -19.4% |
| 2023 | 1.14x | $123.18 Million | $108.45 Million | ▲ +12.4% |
| 2022 | 1.01x | $184.28 Million | $182.31 Million | ▼ -11.0% |
| 2021 | 1.14x | $96.44 Million | $84.96 Million | ▲ +74.2% |
| 2020 | 0.65x | $58.07 Million | $89.14 Million | ▼ -39.4% |
| 2019 | 1.08x | $131.52 Million | $122.33 Million | ▲ +12.3% |
| 2018 | 0.96x | $67.14 Million | $70.15 Million | ▲ +12.7% |
| 2017 | 0.85x | $23.07 Million | $27.16 Million | — |